Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
γ-Secretase inhibitor in combination with BCMA chimeric antigen receptor T-cell immunotherapy for individuals with relapsed or refractory multiple myeloma: a phase 1, first-in-human trial.
Lancet Oncol. 2023 Jul;24(7):811-822. doi: 10.1016/S1470-2045(23)00246-2.
Lancet Oncol. 2023.
PMID: 37414012
Free PMC article.
Clinical Trial.
Dose-dense brentuximab vedotin plus ifosfamide, carboplatin, and etoposide for second-line treatment of relapsed or refractory classical Hodgkin lymphoma: a single centre, phase 1/2 study.
Lynch RC, Cassaday RD, Smith SD, Fromm JR, Cowan AJ, Warren EH, Shadman MS, Shustov A, Till BG, Ujjani CS, Libby EN 3rd, Philip M, Coye H, Martino CN, Bhark SL, Morris K, Rasmussen H, Behnia S, Voutsinas J, Gopal AK.
Lynch RC, et al. Among authors: libby en 3rd.
Lancet Haematol. 2021 Aug;8(8):e562-e571. doi: 10.1016/S2352-3026(21)00170-8.
Lancet Haematol. 2021.
PMID: 34329577
Free PMC article.
Clinical Trial.
Item in Clipboard
A pilot study of weekly brentuximab vedotin in patients with CD30+ malignancies resistant to brentuximab vedotin every 3 weeks.
Poston JN, Fromm JR, Rasmussen HA, Shustov AR, Libby EN 3rd, Smith SD, Gooley T, Gopal AK.
Poston JN, et al. Among authors: libby en 3rd.
Br J Haematol. 2019 Jul;186(1):159-162. doi: 10.1111/bjh.15742. Epub 2018 Dec 28.
Br J Haematol. 2019.
PMID: 30592026
Free PMC article.
No abstract available.
Item in Clipboard
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission.
Cowan AJ, Stevenson PA, Cassaday RD, Graf SA, Fromm JR, Wu D, Holmberg LA, Till BG, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR, Green DJ, Libby EN 3rd, Bensinger WI, Shadman M, Maloney DG, Press OW, Gopal AK.
Cowan AJ, et al. Among authors: libby en 3rd.
Biol Blood Marrow Transplant. 2016 Feb;22(2):380-385. doi: 10.1016/j.bbmt.2015.08.035. Epub 2015 Sep 5.
Biol Blood Marrow Transplant. 2016.
PMID: 26348890
Free PMC article.
Item in Clipboard
Maintenance rituximab after autologous stem cell transplantation in patients with mantle cell lymphoma.
Graf SA, Stevenson PA, Holmberg LA, Till BG, Press OW, Chauncey TR, Smith SD, Philip M, Orozco JJ, Shustov AR, Green DJ, Libby EN 3rd, Bensinger WI, Pagel JM, Maloney DG, Zhou Y, Cassaday RD, Gopal AK.
Graf SA, et al. Among authors: libby en 3rd.
Ann Oncol. 2015 Nov;26(11):2323-8. doi: 10.1093/annonc/mdv364. Epub 2015 Sep 7.
Ann Oncol. 2015.
PMID: 26347113
Free PMC article.
Item in Clipboard
Autologous transplant for relapsed follicular lymphoma: impact of pre-transplant rituximab sensitivity.
Phipps C, Gopal AK, Storer BE, Cassaday RD, Press OW, Till BG, Pagel JM, Palanca-Wessels MC, Philip M, Bensinger WI, Holmberg LA, Shustov AR, Green DJ, Chauncey T, Maloney DG, Libby EN 3rd.
Phipps C, et al. Among authors: libby en 3rd.
Leuk Lymphoma. 2015 Jan;56(1):92-6. doi: 10.3109/10428194.2014.911866. Epub 2014 Jun 17.
Leuk Lymphoma. 2015.
PMID: 24707941
Free PMC article.
Item in Clipboard
Cite
Cite